3Ps augmenting drug discovery in APAC
Beyond meeting the needs of global pharma in simply providing access to patient pools and lower operational costs, the Asia-Pacific (APAC) region is also poised to realize the potential of a thriving biotechnology sector that is driving innovation on its own. APAC is gaining the experience and infrastructure needed to support the global biotech industry by performing work and fostering innovation through public private partnership (3Ps) that is moving up the pharmaceutical value chain.
The BioSpectrum India edition was launched in March 2003 and is India's first comprehensive biotech business monthly magazine. It provides comprehensive coverage of the exciting happenings in life sciences, which include BioPharma, BioAgriculture, BioInformatics, BioIndustrial, BioSuppliers and BioServices and show cases the emerging Indian entrepreneurships in biotech industry. In a short time BioSpectrum has emerged as the most preferred platform to engage the life sciences industry in India and Asia Pacific. It is also widely accepted by research and academia community. Top key policy makers in the Central and state government use the magazine as a platform to reach out the Indian Biotech Industry. BioSpectrum has columns by Indian's top policy makers, biotechnology professionals, scientists and NGOs. Readers of BioSpectrum are from among the key Policy Makers, Key Executives and the Influencer's in Biotechnology, Pharmaceutical Companies, Research Heads of Clinical Research, Clinical Trials and Contract Mfg Organizations, Educational Institutes, Consultants, Fund Managers etc
